Catalyst Wire Dossier Catalyst Wire Dossier

Viramune

Nevirapine · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

34 regulatory and trial events tracked for Viramune, covering 2007-10-01 to 2026-04-07. Get the full timeline:

Most recent: EMA Authorised: Viramune (nevirapine) — Boehringer Ingelheim International GmbH

See pricing